Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance

被引:522
作者
Bloom, Jesse D. [1 ]
Gong, Lizhi Ian [1 ]
Baltimore, David [1 ]
机构
[1] CALTECH, Div Biol, Pasadena, CA 91125 USA
关键词
NEURAMINIDASE INHIBITORS; A VIRUS; ANTIBIOTIC-RESISTANCE; PROTEIN; TRANSMISSION; REPLICATION; STABILITY; SEGMENTS; MUTANTS;
D O I
10.1126/science.1187816
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The His(274)-> Tyr(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidase but had long been thought to compromise viral fitness. However, beginning in 2007-2008, viruses containing H274Y rapidly became predominant among human seasonal H1N1 isolates. We show that H274Y decreases the amount of neuraminidase that reaches the cell surface and that this defect can be counteracted by secondary mutations that also restore viral fitness. Two such mutations occurred in seasonal H1N1 shortly before the widespread appearance of H274Y. The evolution of oseltamivir resistance was therefore enabled by "permissive" mutations that allowed the virus to tolerate subsequent occurrences of H274Y. An understanding of this process may provide a basis for predicting the evolution of oseltamivir resistance in other influenza strains.
引用
收藏
页码:1272 / 1275
页数:4
相关论文
共 32 条
  • [1] Abed Y, 2004, ANTIVIR THER, V9, P577
  • [2] Protein stability promotes evolvability
    Bloom, JD
    Labthavikul, ST
    Otey, CR
    Arnold, FH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) : 5869 - 5874
  • [3] Inferring Stabilizing Mutations from Protein Phylogenies: Application to Influenza Hemagglutinin
    Bloom, Jesse D.
    Glassman, Matthew J.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2009, 5 (04)
  • [4] Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
    Collins, Patrick J.
    Haire, Lesley F.
    Lin, Yi Pu
    Liu, Junfeng
    Russell, Rupert J.
    Walker, Philip A.
    Skehel, John J.
    Martin, Stephen R.
    Hay, Alan J.
    Gamblin, Steven J.
    [J]. NATURE, 2008, 453 (7199) : 1258 - U61
  • [5] Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
    Gubareva, LV
    Kaiser, L
    Matrosovich, MN
    Soo-Hoo, Y
    Hayden, FG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) : 523 - 531
  • [6] Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets
    Herlocher, ML
    Truscon, R
    Elias, S
    Yen, HL
    Roberts, NA
    Ohmit, SE
    Monto, AS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) : 1627 - 1630
  • [7] The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
    Ives, JAL
    Carr, JA
    Mendel, DB
    Tai, CY
    Lambkin, R
    Kelly, L
    Oxford, JS
    Hayden, FG
    Roberts, NA
    [J]. ANTIVIRAL RESEARCH, 2002, 55 (02) : 307 - 317
  • [8] Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic
    Johnson, NPAS
    Mueller, J
    [J]. BULLETIN OF THE HISTORY OF MEDICINE, 2002, 76 (01) : 105 - 115
  • [9] Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
    Kelleher, AD
    Long, C
    Holmes, EC
    Allen, RL
    Wilson, J
    Conlon, C
    Workman, C
    Shaunak, S
    Olson, K
    Goulder, P
    Brander, C
    Ogg, G
    Sullivan, JS
    Dyer, W
    Jones, I
    McMichael, AJ
    Rowland-Jones, S
    Phillips, RE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) : 375 - 385
  • [10] Kramarz P, 2009, EUROSURVEILLANCE, V14